Registration Dossier
Registration Dossier
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 486-080-1 | CAS number: 924626-15-3
Endpoint summary
Administrative data
Description of key information
NOEL (28d, rat, oral) = 300 mg/kg bw/day (sub-acute)
Target organ: digestive: liver
NOAEL (28d, rat, oral) ≥ 1000 mg/kg bw/day (sub-acute)
Target organ: digestive: liver
Key value for chemical safety assessment
Additional information
In a 28-d oral toxicity study in the rat (doses: 0, 100, 300 and 1000 mg/kg bw/d by gavage; vehicle: 0.5% aqueous hydroxypropylmethylcellulosegel), a NOEL of 300 mg/kg bw /d was derived. Oral treatment with 1000 mg/kg bw /d for 28 days led to increased relative and absolute liver weights in the male rats. Additionally, histopathology revealed a mild diffuse hepatocellular hypertrophy in the liver of the high dosed male rats. All signs were completely reversible at the end of the recovery period (14 days).
There were no effects on food consumption, the eye or optic region and the body weight. Macroscopic post mortem examinations, clinical biochemistry and haematology revealed no test item related changes in the treated animals. None of the rats died prematurely. The initiation of a sub-chronic dermal or inhalation study is currently not considered to be required.
Justification for classification or non-classification
No classification and labelling of SymHelios 1031 according to regulation (EC) 1272/2008 as specific target organ toxicant (STOT) – repeated exposure, oral is necessary, since the guidance value for a Category 1 classification of C<30 mg test substance/kg bw/day (based on sub-acute toxicity study), and the guidance value for a Category 2 classification of 30 <C<300 mg test substance/kg bw/day (based on sub-acute toxicity study) are not met. The NOEL is derived at 300 mg/kg bw/d.
Furthermore, no classification and labelling according to regulation (EC) 1272/2008 are expected for long term oral, dermal and inhalation are expected
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
